Followers | 71 |
Posts | 3858 |
Boards Moderated | 0 |
Alias Born | 03/20/2010 |
Monday, August 21, 2017 12:26:09 PM
New Effort will bring the Cann10 Medical Cannabis Model to USA, Canada and Mexico.
August 21, 2017 Blue Diamond Ventures Inc. (OTC PK: BLDV) – Denver Colorado:
Blue Diamond filed its Mid-Term Report today and confirmed that Cann10 the leading Israeli Cannabis
Group and BLDV have agreed to terms to bring the Cann10 Model to North America. Cann10 has
recently completed its second critically acclaimed Medical Conference in Israel and has now begun the
process of expanding the Cann10 package to Australia, Europe and more.
The new venture will be located in Toronto and will responsible for not only bringing the Conference to
the U.S. Canada and Mexico, combined with Education and Training, but will also start to position
Cannabis Manufacturing Procedures and Technologies from the Cann10 and their Cultivation & Process
partners like Seach Farms, for capitalization in North America.
Cann10 recognizes the current state of the Medical Marijuana markets in most of the world and is
committed to providing professional education and leadership in the Medical Cannabis Field to elevate
the industry to the new standards being developed in Israel. “Blue Diamond Ventures was able to
demonstrate specific and substantial value to Cann10, including 40 years’ experience in business with
Israel and attention to Science combined with Business Development, and significant Foreign JV
Experience” said Josh Alper CEO of BLDV.
The parties are expected to finalize agreements in the next 30 days.
About BLDV:
Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy,
mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural
resources. As a diversified customer, centric Management / Holding Company; Blue Diamond Ventures, Inc. seeks
opportunities in various markets and is driven by critical thinking and the scientific method.
Safe Harbor:
This press release contains forward-looking statements. Such forward-looking statements are subject to several
risks, assumptions, and uncertainties that could cause the Company's actual results to differ materially from those
projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees
of future performance.
Contact:
Blue Diamond Ventures Inc. 535 N. Michigan Ave. Suite 300
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM